Related Experiment Video
Updated: Oct 8, 2025

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
BRCA2 represses the transcriptional activity of pS2 by E2-ERα
Mio Fukuda1, Yo Tojo2, Ami Sato2
1Department of Specialized Surgeries, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
Abstract:
Germline mutations to the breast cancer 2 (BRCA2) gene have been associated with hereditary breast cancer. In addition to estrogen uptake, BRCA2 expression increases in the S phase of the cell cycle and largely contributes to DNA damage repair associated with DNA replication. However, the role of BRCA2 in estrogen induction remains unclear. An expression plasmid was created to induce BRCA2 activation upon the addition of estradiol by introducing mutations to the binding sequences for the transcription factors USF1, E2F1, and NF-κB within the promoter region of BRCA2. Then, the estrogen receptor (ER) sites of the proteins that interact with BRCA2 upon the addition of estradiol were identified. Both proteins were bound by the helical domain of BRCA2 and activation function-2 of the ER, suggesting that this binding may regulate the transcriptional activity of pS2, a target gene of the estradiol-ER, by suppressing the binding of SRC-1, a coactivator required for activation of the transcription factor.
Insights
This study reveals how BRCA2 interacts with the estrogen receptor (ER) to regulate gene expression. Understanding this BRCA2-ER pathway is crucial for hereditary breast cancer research.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Germline mutations in the breast cancer 2 (BRCA2) gene are linked to hereditary breast cancer.
- BRCA2 expression rises during the S phase of the cell cycle, aiding DNA repair.
- The specific role of BRCA2 in estrogen-induced gene expression is not well understood.
Purpose of the Study:
- To investigate the mechanism by which BRCA2 is activated by estrogen.
- To identify proteins interacting with BRCA2 upon estradiol stimulation.
- To elucidate how BRCA2 influences the transcriptional activity of estrogen-responsive genes.
Main Methods:
- Constructed an expression plasmid to induce BRCA2 activation with estradiol.
- Mutated transcription factor binding sites (USF1, E2F1, NF-κB) in the BRCA2 promoter.
- Identified estrogen receptor (ER) interacting proteins using estradiol.
- Characterized protein-BRCA2 and ER interactions.
Main Results:
- Identified proteins that bind to BRCA2 upon estradiol addition.
- Demonstrated that the helical domain of BRCA2 binds to activation function-2 of the ER.
- Showed that this interaction may suppress SRC-1 coactivator binding to the pS2 gene promoter.
Conclusions:
- BRCA2's interaction with the ER is a key regulatory mechanism in estrogen-induced gene expression.
- This pathway involves the suppression of coactivator binding, impacting the transcription of estrogen-responsive genes like pS2.
- Findings provide insights into BRCA2's function beyond DNA repair, particularly in the context of hormone-driven cancers.
Related Concept Videos
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Negative Regulator Molecules
Abnormal Proliferation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Master Transcription Regulators

